InsidersTradesSigma
Track the 엑세스바이오 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 엑세스바이오 has recorded 1 reports. Market capitalisation: €75.8bn. The latest transaction was filed on 12 March 2026 (Other). Among the most active insiders: 엑세스바이오. Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Access Bio se encuentra en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. La empresa se especializa en el desarrollo de diagnósticos médicos innovadores.